Aspirin may boost survival in these two cancers

In a new study, researchers found that aspirin use may improve survival for bladder and breast cancer.

The research was conducted by a team from the National Cancer Institute in Rockville.

In the study, the team examined the association of aspirin use with the risk for developing new cancers, as well as cancer-associated survival for bladder, breast, esophageal, gastric, pancreatic, and uterine cancers.

Their analysis included 139,896 people (mean age, 66.4 years) participating in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (1993 to 2001).

The researchers found that aspirin use was not linked to the incidence of any studied cancer type.

Aspirin use at least three times/week was linked to increased survival among patients with bladder and breast cancers.

However, there was no survival benefit with esophageal, gastric, pancreatic, or uterine cancer.

A similar association for bladder and breast cancer was seen for any aspirin use.

The results add to the accumulating evidence that aspirin may improve survival for some cancers, the team says.

One author of the study is Holli A. Loomans-Kropp, Ph.D., M.P.H.

The study is published in JAMA Network Open.

Copyright © 2021 Knowridge Science Report. All rights reserved.